Fundraising Fox
Vincere Biosciences
Founded 2018 · 10 employees on LinkedIn · 8 known investors
Find your way into Vincere Biosciences
Sign up to see every warm intro you have to Vincere Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vincere Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Vincere Biosciences develops small-molecule therapeutics targeting mitochondrial quality control and mitophagy, primarily for neurodegenerative diseases including Parkinson's disease. The company translates computational biology and drug discovery into disease-modifying treatments for CNS disorders.
Investors · 8
How we know: av.vc · Not right? Tell us
How we know: Draper Associates's portfolio page · Not right? Tell us
How we know: Freemind Investments's portfolio page · Not right? Tell us
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $470.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $299.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $252K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Vincere Biosciences do?
- Vincere Biosciences develops small-molecule therapeutics targeting mitochondrial quality control and mitophagy, primarily for neurodegenerative diseases including Parkinson's disease. The company translates computational biology and drug discovery into disease-modifying treatments for CNS disorders.
- Who are Vincere Biosciences's investors?
- Vincere Biosciences's investors include Alumni Ventures, Beiersdorf Innovation Fund, Beresford Ventures, Draper Associates, Freemind Investments, Long Game, Portal Innovations, quadraScope Venture Fund.